Endpoint definition
↥| Name | K11_OESITIS_ADVERSE |
|---|---|
| Long name | Oesophagitis, drug-induced |
| Hospital Discharge registry | ICD-10: K20 |
| Hospital Discharge: ATC drug used | ANY |
| Level in the ICD-hierarchy | C |
| First defined in version | DF5 |
| Latin name | Oesophagitis |
| Name | K11_OESITIS_ADVERSE |
|---|---|
| Long name | Oesophagitis, drug-induced |
| Hospital Discharge registry | ICD-10: K20 |
| Hospital Discharge: ATC drug used | ANY |
| Level in the ICD-hierarchy | C |
| First defined in version | DF5 |
| Latin name | Oesophagitis |
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 37 | 21 | 16 |
| Unadjusted prevalence (%) | 0.02 | 0.02 | 0.02 |
| Mean age at first event (years) | 47.01 | 43.66 | 51.41 |
| Case fatality at 5-years (%) | 2.70 | 0.00 | 6.25 |
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 1.0 | 1.0 | 1.0 |
| Recurrence at 6 months (%) | 5.41 | - | 12.50 |
before Oesophagitis, drug-induced
after Oesophagitis, drug-induced
Loading survival analyses plot…
Loading survival analyses table…